Evidence map›Paper›PMID 36509769›Full record

ArticleNature communications2022

Radiative anti-parity-time plasmonics.

Yumeng Yang, Xinrong Xie, Yuanzhen Li, Zijian Zhang, Yiwei Peng, Chi Wang, Erping Li, Ying Li, Hongsheng Chen, Fei Gao

Abstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Level pinning of anti-National science review · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yumeng Yang *Interdisciplinary Center for Quantum Information, State Key Laboratory of Extreme Photonics and Instrumentation, ZJU-Hangzhou Global Scientific and Technological Innovation Center, Zhejiang University, Hangzhou, 310027, China.
Xinrong Xie *Interdisciplinary Center for Quantum Information, State Key Laboratory of Extreme Photonics and Instrumentation, ZJU-Hangzhou Global Scientific and Technological Innovation Center, Zhejiang University, Hangzhou, 310027, China.
Yuanzhen LiInterdisciplinary Center for Quantum Information, State Key Laboratory of Extreme Photonics and Instrumentation, ZJU-Hangzhou Global Scientific and Technological Innovation Center, Zhejiang University, Hangzhou, 310027, China.
Zijian ZhangInterdisciplinary Center for Quantum Information, State Key Laboratory of Extreme Photonics and Instrumentation, ZJU-Hangzhou Global Scientific and Technological Innovation Center, Zhejiang University, Hangzhou, 310027, China.
Yiwei PengInterdisciplinary Center for Quantum Information, State Key Laboratory of Extreme Photonics and Instrumentation, ZJU-Hangzhou Global Scientific and Technological Innovation Center, Zhejiang University, Hangzhou, 310027, China.
Chi WangInterdisciplinary Center for Quantum Information, State Key Laboratory of Extreme Photonics and Instrumentation, ZJU-Hangzhou Global Scientific and Technological Innovation Center, Zhejiang University, Hangzhou, 310027, China.
Erping LiInterdisciplinary Center for Quantum Information, State Key Laboratory of Extreme Photonics and Instrumentation, ZJU-Hangzhou Global Scientific and Technological Innovation Center, Zhejiang University, Hangzhou, 310027, China.ORCID http://orcid.org/0000-0002-5006-7399
Ying LiInterdisciplinary Center for Quantum Information, State Key Laboratory of Extreme Photonics and Instrumentation, ZJU-Hangzhou Global Scientific and Technological Innovation Center, Zhejiang University, Hangzhou, 310027, China.ORCID http://orcid.org/0000-0002-2730-7171
Hongsheng ChenInterdisciplinary Center for Quantum Information, State Key Laboratory of Extreme Photonics and Instrumentation, ZJU-Hangzhou Global Scientific and Technological Innovation Center, Zhejiang University, Hangzhou, 310027, China. hansomchen@zju.edu.cn.ORCID http://orcid.org/0000-0002-5735-9781
Fei GaoInterdisciplinary Center for Quantum Information, State Key Laboratory of Extreme Photonics and Instrumentation, ZJU-Hangzhou Global Scientific and Technological Innovation Center, Zhejiang University, Hangzhou, 310027, China. gaofeizju@zju.edu.cn.ORCID http://orcid.org/0000-0001-9928-9390

Funding

National Natural Science Foundation of China (National Science Foundation of China) 11961141010National Natural Science Foundation of China (National Science Foundation of China) 61975176National Natural Science Foundation of China (National Science Foundation of China) 62171406National Natural Science Foundation of China (National Science Foundation of China) 92163123
6 · The paper itself

Abstract

Space and guided electromagnetic waves, as widely known, are two crucial cornerstones in extensive wireless and integrated applications respectively. To harness the two cornerstones, radiative and integrated devices are usually developed in parallel based on the same physical principles. An emerging mechanism, i.e., anti-parity-time (APT) symmetry originated from non-Hermitian quantum mechanics, has led to fruitful phenomena in harnessing guided waves. However, it is still absent in harnessing space waves. Here, we propose a radiative plasmonic APT design to harness space waves, and experimentally demonstrate it with subwavelength designer-plasmonic structures. We observe two exotic phenomena unrealized previously. Rotating polarizations of incident space waves, we realize polarization-controlled APT phase transition. Tuning incidence angles, we observe multi-stage APT phase transition in higher-order APT systems, constructed by using the scalability of leaky-wave couplings. Our scheme shows promise in demonstrating novel APT physics, and constructing APT-symmetry-empowered radiative devices.

Identifiers

PMID36509769
PMCPMC9744817

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.